Login / Signup

Single-center Outcomes After Liver Transplantation With SARS-CoV-2-Positive Donors: An Argument for Increased Utilization.

Ashton A ConnorMax W AdelmanConstance M MobleyMozhgon MoaddabAlexandra J ErhardtDavid E HsuElizabeth W BromboszMansi SanghviYee Lee CheahCaroline J SimonMark J HobeikaAshish S SahariaDavid W VictorSudha KodaliTamneet BasraEdward A GravissAngelina M AlbertAhmed ElsaieyLinda W MooreMasayuki NigoAshley L DrewsKevin A GrimesCésar A AriasXian Chang LiA Osama GaberR Mark Ghobrial
Published in: Transplantation direct (2024)
The utilization of liver grafts from COVID-19-positive donors was not associated with a decreased overall survival of recipients. There was no suggestion of viral transmission from donor to recipient. The results from this large single-center study suggest that COVID-19-positive donors may be used safely to expand the deceased donor pool.
Keyphrases
  • sars cov
  • kidney transplantation
  • coronavirus disease
  • respiratory syndrome coronavirus
  • type diabetes
  • metabolic syndrome
  • adipose tissue
  • weight loss
  • glycemic control